CH IDMP (R5)
1.0.0-ballot - trial-use Switzerland flag

CH IDMP (R5) - Local Development build (v1.0.0-ballot) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

Example MedicinalProductDefinition: Xospata 40 mg, Filmtabletten

CH SMC - Authorized Dose Form: Film-coated tablet

identifier: Medical Product Identifier/CH-01100869-0672110010000

indication:

Xospata wird angewendet für die Behandlung von erwachsenen Patienten, die an rezidivierter oder refraktärer akuter myeloider Leukämie (AML) mit FMS-ähnlichen Tyrosinkinase 3 (FLT3)-Mutationen leiden.

legalStatusOfSupply: A: Single dispensing requiring a medical or veterinary prescription

additionalMonitoringIndicator: No Warning

pediatricUseIndicator: Not authorised for the treatment in children

classification: gilteritinib, Synthetic

MarketingStatuses

-CountryStatusDateRange
*SwitzerlandNo interruption of distribution reported2020-09-24 --> (ongoing)

attachedDocument:

name

productName: Xospata 40 mg, Filmtabletten

Usages

-CountryLanguage
*SwitzerlandGerman (Switzerland)